<DOC>
	<DOCNO>NCT01186432</DOCNO>
	<brief_summary>This study evaluate preliminary safety efficacy PDS 1.0 patient neovascular AMD .</brief_summary>
	<brief_title>Preliminary Safety Efficacy PDS-1.0 Patients With Neovascular Age Related Macular Degeneration ( AMD )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Diagnosis CNV secondary AMD confirm fluorescein angiography , previously treat Retinal thickness due edema least 300um study eye Best correct visual acuity 20/40 worse study eye Best correct visual acuity 20/40 good fellow eye Evidence scar CNV ( e.g . geographic atrophy ) study eye Fibrosis &gt; 75 % lesion area study eye</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>